Ethical Considerations in the Selection of Cells and the use of Biologicals
Dr. Bruce Dull has discussed in-depth the benefit risk assessment in the development of and usage of immunizing agents. It is my task to cover the wide range of other ethical considerations which face investigators and makers of public policy concerned with immunization. Many of the issues have been explored in-depth at a National Conference on Immunization sponsored by HEW in November 1976, and by a series of National Immunization Work Groups convened by the Assistant Secretary for Health of Health, Education and Welfare thereafter.
KeywordsEthical Consideration Vaccine Development National Commission Vaccine Trial Benefit Risk Assessment
Unable to display preview. Download preview PDF.
- 1.Appendix B-2 Report and Recommendations of the National Immunization Work Groups submitted to the Office of the Assistant Secretary for Health. JRB Associates, Inc. March 15, 1977.Google Scholar
- 2.National Immunization Conference, Policy Perspective, HEW., P.H. S. November 1976. DHEW Publication # (OS) 77-50039 p.8Google Scholar
- 3.Report and Recommendations: Research Involving Children. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, DHEW Publication No. (OS) 77–0004.Google Scholar